Literature DB >> 26088674

Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab.

C S Tan1,2, W K Ngo2, L W Lim2, T H Lim1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26088674      PMCID： PMC4565937          DOI： 10.1038/eye.2015.101

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage.

Authors:  C S H Tan; H-T Wong; B-A Lim; O K Hee; T H Lim
Journal:  Eye (Lond)       Date:  2006-06-09       Impact factor: 3.775

2.  Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.

Authors:  M Ho; E C F Lo; A L Young; D T L Liu
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

3.  A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes.

Authors:  Colin S H Tan; Wei Kiong Ngo; Louis W Lim; Tock Han Lim
Journal:  Br J Ophthalmol       Date:  2014-07-04       Impact factor: 4.638

4.  Polypoidal choroidal vasculopathy: an angiographic discussion.

Authors:  T H Lim; A Laude; C S H Tan
Journal:  Eye (Lond)       Date:  2010-01-15       Impact factor: 3.775

5.  EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.

Authors:  Colin S Tan; Wei Kiong Ngo; Jian Ping Chen; Nikolle W Tan; Tock Han Lim
Journal:  Br J Ophthalmol       Date:  2015-03-10       Impact factor: 4.638
  5 in total
  2 in total

1.  Reply to 'Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab'.

Authors:  M Ho; E C Lo; A L Young; D T L Liu
Journal:  Eye (Lond)       Date:  2015-06-19       Impact factor: 3.775

2.  Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy.

Authors:  I-Hsin Ma; Yun Hsia; Yi-Ting Hsieh; Tzyy-Chang Ho; Tso-Ting Lai; Chung-May Yang; Chang-Hao Yang
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.